𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The role of monoclonal antibody A7 as a drug modifier in cancer therapy

✍ Scribed by K. Kitamura; T. Miyagaki; N. Yamaoka; H. Tsurumi; A. Noguchi; T. Yamaguchi; T. Takahashi

Publisher
Springer-Verlag
Year
1993
Tongue
English
Weight
1024 KB
Volume
36
Category
Article
ISSN
0340-7004

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Monoclonal antibody drug conjugates in t
Monoclonal antibody drug conjugates in the treatment of cancer
✍ Pamela A Trail; Albert B Bianchi πŸ“‚ Article πŸ“… 1999 πŸ› Elsevier Science 🌐 English βš– 79 KB

Monoclonal antibodies directed to tumor-associated antigens have been chemically conjugated to drugs with different mechanisms of action and different levels of potency. Monoclonal-antibody-directed drug delivery has the potential to both improve efficacy and reduce systemic toxicity. Several immuno

Intratumoral administration of neocarzin
Intratumoral administration of neocarzinostatin conjugated to monoclonal antibody A7 in a model of pancreatic cancer
✍ Dr. Eigo Otsuji; Toshiharu Yamaguchi; Nobuki Yamaoka; Kazuya Kitamura; Nozomi Ya πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 533 KB

## Abstract We investigated the following in athymic nude mice with xenografts of a human pancreatic carcinoma: 1) clearance of the murine monoclonal antibody A7 from the carcinoma; and 2) the antitumor effect of neocarzinostatin conjugated to MAb A7 (A7‐NCS) on the carcinoma following intratumoral

Infectious complications of monoclonal a
Infectious complications of monoclonal antibodies used in cancer therapy : A systematic review of the evidence from randomized controlled trials
✍ Petros I. Rafailidis; Ourania K. Kakisi; Konstantinos Vardakas; Matthew E. Falag πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 106 KB πŸ‘ 2 views

## Abstract The introduction of monoclonal antibodies (MoAbs) into the treatment of cancer has led to improvements in patient survival. However, to the authors' knowledge, little attention has been paid to the infectious complications associated with their use. The authors performed a systematic re

Use of anti-CD40 ligand monoclonal antib
Use of anti-CD40 ligand monoclonal antibody as antirejection therapy in a murine peripheral nerve allograft model
✍ John N. Jensen; Thomas H.H. Tung; Susan E. Mackinnon; Michael J. Brenner; Daniel πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 298 KB

Monoclonal antibody directed against CD40 ligand prevents acute allograft rejection in several models of solid-organ transplantation. This study describes the use of CD40 ligand as antirejection therapy in a mouse peripheral nerve allograft model. C3H mice received 8-mm nerve isografts (n = 2) or ne